BJDX Bluejay Diagnostics, Inc.: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

bluejaydx.com - graphic logo of issuer BJDX

The market valuation of Bluejay Diagnostics (BJDX) on the GURU.Markets platform is visually presented as 0.00. The business is resilient to economic downturns, as urgent diagnostics remain in constant demand. Bluejay Diagnostics (BJDX) develops compact devices for instantaneous patient blood analysis, reducing diagnosis time. Growth prospects rely on the implementation of sepsis detection tests in intensive care units, regardless of market conditions.

Bluejay - BJDX Total Company Value to Operating Income Before Depreciation Ratio (period 11/23/2025 - 11/10/2026)

bluejaydx.com (BJDX) - metric breakdowns and financial figures

- stock price and consensus target price:
Stock Quotes Bluejay|BJDX - Average Forecast Price
- company stock capitalization data:
Market Value Bluejay Diagnostics Corp|BJDX - Company Buyout Price
- book value of equity indicators:
Book Value per Share Bluejay Diagnostics|BJDX - Book Valuation of Business|Market Value to Book Value Ratio bluejaydx.com|BJDX - Company Total Asset Base
- company liabilities and liquidity data:
Total Debt to Capital Bluejay Diagnostics|BJDX - Long-Term Debt to Equity|Short-Term Debt to Equity Bluejay Diagnostics, Inc.|BJDX - Company Debts|Debt to Book Value Bluejay Diagnostics Corp|BJDX - Company Long-Term Debts|Company Short-Term Debts Bluejay Diagnostics|Quick Liquidity bluejaydx.com
- financial results and valuation multiples details:
BJDX - Profit After Payment of Taxes|Projected Future Earnings Bluejay Diagnostics|BJDX - P/E Multiple|Projected Price to Earnings Bluejay Diagnostics|BJDX - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Bluejay Diagnostics Corp|BJDX - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Bluejay Diagnostics|BJDX - Earnings per share for the last 12 months|Quarterly EPS earnings growth bluejaydx.com|BJDX - Expected net earnings per share growth this year|Earnings growth forecast for next year Bluejay Diagnostics
Summary company analytics:Bluejay (BJDX)
Product sample of Bluejay Diagnostics, Inc.

Conservative capital demands full transparency regarding business value, including debt and tax liabilities. The EV/EBITDA ratio measures the actual enterprise value relative to its operating profit, making it possible to identify asset overvaluation or attractive entry points. The high costs and liquidity risks of Bluejay Diagnostics (BJDX) are already priced in, which confirms the shift in the company's EV/EBITDA level.

Competitors of Bluejay Diagnostics

Agilent Tech - Enterprise Value to EBITDA Ratio|Quest Corp (DGX) - Company Value to EBITDA|ILMN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio exactsciences.com EXAS|RVTY: EV/EBITDA Multiple|BIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Anbio Tech|Nordion (SHC) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple QDEL|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization OPK (opko.com)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CareDx Inc CDNA|Maravai LifeSciences Holdings - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|FLGT: Enterprise Value to EBITDA Ratio|LAB - EV/EBITDA Multiple|CTKB: EV/EBITDA Multiple|Company Value to EBITDA orasure.com (OSUR)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Exagen Inc|MDXH (MDxHealth S.A.) - Enterprise Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple LUCD|EV/EBITDA Multiple prenetics.com (PRE)|Insight Molecular Diagnostics Inc - Enterprise Value to EBITDA Ratio|Trinity Biotech PLC (TRIB) - Company Value to EBITDA|PRPH: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation AIMD (Ainos Inc)|CODX: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation HSCS|BMRA (Biomerica, Inc.) - EV/EBITDA Multiple|Cardio Diagnostics Holdings, Inc. (CDIO) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple ONCO|EV/EBITDA Multiple Virax Biolabs Group Limited (VRAX)|EV/EBITDA Multiple AWH (Vermillion)|Enterprise Value to EBITDA Multiple Accelerate Diagnostics Inc|CNTG - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ENZ (Enzo Biochem, Inc.) - Enterprise Value to Operating Income Before Depreciation|fresh2.co (FRES) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Genetic Technologies Limited (GENE)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization 23andMe Inc.|Psychemedics Inc (PMD) - Total Company Value to Operating Income Before Depreciation Ratio